Insurance, Health, Accident - As enacted, requires a health insurer that issues, amends, delivers, or renews a contract or agreement for a health benefit plan to take effect on or after January 1, 2027, to include coverage for biomarker testing; requires a TennCare health benefit plan that is issued, amended, or renewed on or after January 1, 2027, to provide coverage for biomarker testing when medically necessary. - Amends TCA Title 56 and Title 71.

Summary

The bill mandates that any health benefit plan issued, amended, delivered, or renewed on or after Jan. 1, 2026 must include coverage for biomarker testing when supported by FDA approval, clinical guidelines, or Medicare determinations. It applies to private insurers and TennCare plans, setting timelines for prior‑authorization decisions and a clear appeals process.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share